Trichomonas vaginalis treatment reduces vaginal HIV-1 shedding
about
Neglected parasitic infections and poverty in the United StatesTrichomoniasis and HIV interactions: a reviewClinical and Laboratory Testing for Trichomonas vaginalis InfectionThe Role of Sexually Transmitted Infections in HIV-1 Progression: A Comprehensive Review of the LiteratureTrichomonas vaginalis: a review of epidemiologic, clinical and treatment issuesMicrobiota and pelvic inflammatory diseaseTrichomonas vaginalis screening and prevention in order to impact the HIV pandemic: Isn't it time we take this infection seriously?Genetic identity and differential gene expression between Trichomonas vaginalis and Trichomonas tenaxNeglected parasitic infections in the United States: trichomoniasis.The Gulf Coast: a new American underbelly of tropical diseases and poverty.Non-sexual transmission of Trichomonas vaginalis in adolescent girls attending school in Ndola, Zambia.A prospective study of vaginal trichomoniasis and HIV-1 shedding in women on antiretroviral therapy.Prevalence of Trichomonas vaginalis and coinfection with Chlamydia trachomatis and Neisseria gonorrhoeae in the United States as determined by the Aptima Trichomonas vaginalis nucleic acid amplification assay.Female epidemiology of transcription-mediated amplification-based Trichomonas vaginalis detection in a metropolitan setting with a high prevalence of sexually transmitted infectionSexually transmitted infections associated syndromes assisted in the primary health care in Northeast, Brazil.Trichomoniasis: the "neglected" sexually transmitted disease.Sexually transmitted diseases treatment guidelines, 2015.Preventing unintended pregnancy and HIV transmission: effects of the HIV treatment cascade on contraceptive use and choice in rural KwaZulu-Natal.A randomized treatment trial: single versus 7-day dose of metronidazole for the treatment of Trichomonas vaginalis among HIV-infected womenComparison of Aptima Trichomonas vaginalis transcription-mediated amplification assay and BD affirm VPIII for detection of T. vaginalis in symptomatic women: performance parameters and epidemiological implications.Interactions of HIV, other sexually transmitted diseases, and genital tract inflammation facilitating local pathogen transmission and acquisition.Trichomoniasis and other sexually transmitted infections: results from the 2001-2004 National Health and Nutrition Examination SurveysLower Genital Tract Infections in HIV-Infected Women: Can We Afford to Miss?Trichomonas vaginalis infection in women who submit self-obtained vaginal samples after internet recruitmentIn vitro trichomonacidal activity and preliminary in silico chemometric studies of 5-nitroindazolin-3-one and 3-alkoxy-5-nitroindazole derivatives.Permissive and protective factors associated with presence, level, and longitudinal pattern of cervicovaginal HIV sheddingUse of nucleic acid amplification testing for diagnosis of anorectal sexually transmitted infectionsEpidemiology of Trichomoniasis in South Korea and Increasing Trend in Incidence, Health Insurance Review and Assessment 2009-2014Association between Trichomonas vaginalis and vaginal bacterial community composition among reproductive-age women.A Review of Evidence-Based Care of Symptomatic Trichomoniasis and Asymptomatic Trichomonas vaginalis InfectionsTrichomonas vaginalis in selected U.S. sexually transmitted disease clinics: testing, screening, and prevalenceScreening of male patients for Trichomonas vaginalis with transcription-mediated amplification in a community with a high prevalence of sexually transmitted infection.Interaction between lactobacilli, bacterial vaginosis-associated bacteria, and HIV Type 1 RNA and DNA Genital shedding in U.S. and Kenyan women.STI management and control in North America IUSTI region.Performance of a rapid self-test for detection of Trichomonas vaginalis in South Africa and BrazilPrevalence of Trichomonas vaginalis in Women Visiting 2 Obstetrics and Gynecology Clinics in Daegu, South Korea.Biomarkers of Cervical Inflammation and Immunity Associated with Cervical Shedding of HIV-1IL-22 levels are associated with Trichomonas vaginalis infection in the lower genital tract.A prospective cohort study comparing the effect of single-dose 2 g metronidazole on Trichomonas vaginalis infection in HIV-seropositive versus HIV-seronegative women.Rapid Diagnosis of Trichomonas vaginalis by Testing Vaginal Swabs in an Isothermal Helicase-Dependent AmpliVue Assay
P2860
Q21092273-C399407F-6832-4A6D-A4DA-B0B42EB7C68BQ24630472-AC5FFD40-799C-4C73-AD19-4E80683B86BBQ26778560-5F8031B1-2CB3-4AA9-80B2-97854D6A909DQ26864344-6597CBD9-1267-4A8C-955B-CBD43A3D52C4Q27025282-41BC0C90-2C82-4232-B83C-8265D25D260CQ28305224-EDE851BD-E65E-486C-A50E-F1830CAB529CQ30358403-81C3493C-D351-44D2-B40E-5DF333C0D9FCQ33419511-933DE779-8506-48AF-A875-5C44F8678BE8Q33588454-4978BD9B-E109-4067-A746-0D25AE57D558Q33617699-63F1F08C-1712-4676-9A65-88C682F453A0Q33815797-74AC0567-294C-44E6-9F1C-AC227581328BQ34065082-A181048A-4D5A-4EB0-B2C6-1AEFCB1E7C25Q34276878-A69593AE-9B9C-44FB-B643-CC46377EEDC1Q34302176-57073F90-D4EF-4174-99B0-AE44A428F458Q34361568-F58671C1-862C-4D72-B334-D3DCC1AD633DQ34387759-B1B9CD27-B6AE-4633-98D5-F34470E6CEE9Q34479272-B92F221B-1B41-47D0-8BEE-3F6797041AA3Q34611372-D1731EAF-682C-4613-849B-BD94D8E31D71Q34678232-7AEB5EB1-A407-4657-94A2-6966525D2A6DQ34741096-EAAA647F-C1F6-45B7-B6C2-A2A02D9D032EQ34799419-A2FBB896-888E-449E-B0D7-CD28769BF84EQ35051667-D32448ED-F3CA-44C3-9952-BF3B4299C775Q35126360-72CA3108-5092-4AB3-9CB3-9776E5135B4AQ35167441-038D730C-EACF-4178-A337-84D678DEFF56Q35829594-8FD70856-DFC5-4E3A-8EB2-E371B81EF21EQ35906707-996A606A-6E99-4174-87B7-1A2156BB60B3Q36022965-769780F3-2254-47D4-A228-C50A35F6C381Q36218680-BF1C74A7-1E1C-4F95-AA36-D5A0391B0D33Q36279550-8591AFE0-C8F5-422E-9011-0B30B5FA3953Q36311615-D70E5AD9-AD59-40CA-8006-A059EA3D51E0Q36368342-384CDFBD-1996-4D0F-8D47-0F4528896932Q36506408-6AF703E5-A1C3-45D8-9B70-2D10DE3F028AQ36509620-77076E19-1F94-4060-B259-68C5D5BC2589Q36650578-BFB93CB7-3C8D-455C-9971-6728794A1222Q36667695-BD3F41E0-0DD7-4C6E-A9DB-98B4F7199C81Q36688389-AB110318-F02E-4C0E-80F7-3F6B1FED5758Q36837376-D858434F-1E90-4446-AC80-0312752EA3BCQ36909129-2E949561-194E-4BA8-BD22-08B61F81D17AQ36912247-19702079-DF7F-4F5D-B608-778F8F8D524BQ36921621-5F7AEE2A-B239-4A9F-B828-6CD3286866A6
P2860
Trichomonas vaginalis treatment reduces vaginal HIV-1 shedding
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Trichomonas vaginalis treatment reduces vaginal HIV-1 shedding
@en
Trichomonas vaginalis treatment reduces vaginal HIV-1 shedding.
@nl
type
label
Trichomonas vaginalis treatment reduces vaginal HIV-1 shedding
@en
Trichomonas vaginalis treatment reduces vaginal HIV-1 shedding.
@nl
prefLabel
Trichomonas vaginalis treatment reduces vaginal HIV-1 shedding
@en
Trichomonas vaginalis treatment reduces vaginal HIV-1 shedding.
@nl
P2093
P2860
P1476
Trichomonas vaginalis treatment reduces vaginal HIV-1 shedding
@en
P2093
Angela Amedee
David H Martin
Jeanne Dumestre
Katherine P Theall
Leann Myers
Michael E Hagensee
Patricia Kissinger
Rebecca A Clark
Thomas A Farley
P2860
P356
10.1097/OLQ.0B013E318186DECF
P577
2009-01-01T00:00:00Z